Streptococcus pneumoniae colonization among patients with human immunodeficiency virus-1 who had received 23-valent polysaccharide pneumococcal vaccine

Journal of Microbiology, Immunology and Infection

Volumn 42, Issue 3, 2009, Pages 234-242

  Lo, Yi Chun ^a   Lauderdale, Tsai Ling ^b   Chang, Sui Yuan ^c   Hsiao, Chin Fu ^b   Hung, Chien Ching ^a   Chang, Shan Chwen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Acquired immunodeficiency syndrome; Antiretroviral therapy; Highly active; HIV infections; HIV 1; Pneumococcal vaccines; Streptococcus pneumoniae

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; COTRIMOXAZOLE; MACROLIDE; PENICILLIN DERIVATIVE; PENICILLIN G; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; PNEUMOCOCCAL INFECTION; SMOKING; STREPTOCOCCUS PNEUMONIAE; THROAT CULTURE; TONSIL; UPPER RESPIRATORY TRACT INFECTION; VACCINATION;

ADULT; AGED; CARRIER STATE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RISK FACTORS; SMOKING; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 70349932535     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Nuroti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ. Epidemiologic relationship between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med. 2000;132:182-190
2. Breiman RF, Keller DW, Phelan MA, Sniadack DH, Stephens DS, Rimland D, et al. Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. Arch Intern Med. 2000;160:2633-2638
3. Dworkin MS, Ward JW, Hanson DL, Jones JL, Kaplan JE. Adult and Adolescent Spectrum of HIV Disease Project. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis. 2001;32:794-800.
4. Hung CC, Chen MY, Hsieh SM, Hsiao CF, Sheng WH, Chang SC. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a 2-year prospective observational study. Vaccine. 2004;22:2006-2012
5. Penaranda M, Falco V, Payeras A, Jordano Q, Curran A, Pareja A, et al. Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study. Clin Infect Dis. 2007;45:e82-7. (Pubitemid 47580396)
6. Rusen ID, Fraser-Roberts L, Slaney L, Ombette J, Lovgren M, Datta P, et al. Nasopharyngeal pneumococcal colonization among Kenyan children: antibiotic resistance, strain types and associations with human immunodeficiency virus type 1 infection. Pediatric Infect Dis. 1997;16:656-662 (Pubitemid 27300703)
7. Leibovitz E, Dragomir C, Sfartz S, Porat N, Yagupsky P, Jica S, et al. Nasopharyngeal carriage of multidrug-resistant Streptococcus pneumoniae in institutionalized HIV-infected and HIV-negative children in northeastern Romania. Int J Infect Dis. 1999;3:211-215
8. Polack FP, Flayhart DC, Zahurak ML, Dick JD, Willoughby RE. Colonization by Streptococcus pneumoniae in human immunodeficiency virus-infected children. Pediatr Infect Dis. 2000;19:608-612 (Pubitemid 30469766)
9. Madhi SA, Adrian P, Kuwanda L, Cutland C, Albrich WC, Klugman KP. Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae - and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization - in HIV-infected and HIV-uninfected children. J Infect Dis. 2007;196:1662-1666
10. Janoff EN, O'Brien J, Thompson P, Ehret J, Meiklejohn G, Duvall G, et al. Streptococcus pneumoniae colonization, bacteremia, and immune response among patients with human immunodeficiency virus infection. J Infect Dis. 1993;167:49-56. (Pubitemid 23002836)
11. Rodriguez-Barradas MC, Tharapel RA, Groover JE, Giron KP, Lacke CE, Houston ED, et al. Colonization by Streptococcus pneumoniae among human immunodeficiency virus-infected adults: prevalence of antibiotic resistance, impact of immunization, and characterization by polymerase chain reaction with BOX primers of isolates from persistent 5. pneumoniae carriers. J Infect Dis. 1997;175:590-597
12. Nicoletti C, Cristina M, Brandileone C, Luiza M, Guerra S, Levin AS. Prevalence, serotypes, and risk factors for pneumococcal carriage among HIV-infected adults. Diagn Microbiol Infect Dis. 2007;57:259-265 (Pubitemid 46335942)
13. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. 5th ed. NCCLS document M7-A5. Wayne: National Committee for Clinical Laboratory Standards; 2000.
14. Performance standards for antimicrobial susceptibility testing. 18th informational supplement. CLSI document M100-S17. Wayne: Clinical and Laboratory Standards Institute; 2008.
15. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41(RR-17):1-19.
16. Chen CJ, Huang YC, Su LH, Lin TY. Nasal carriage of Streptococcus pneumoniae in healthy children and adults in northern Taiwan. Diagn Microbiol Infect Dis. 2007;59:265-269
17. Elssner A, Carter JE, Yunger TM, Wewers MD. HIV-1 infection does not impair human alveolar macrophage phagocytic function unless combined with cigarette smoking. Chest. 2004;125:1071-1076 (Pubitemid 38367303)
18. Nielsen H, Kvinesdal R, Benfield L, Lundgren JD, Konradsen HB. Rapid loss of specific antibodies after pneumococcal vaccination in patients with human immunodeficiency virus-1 infection. Scand J Infect Dis. 1998;30:597-661 (Pubitemid 29145749)
19. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4:144-154 (Pubitemid 38293138)
20. Gill CJ, Mwanakasale V, Fox MP, et al. Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women. J Infect Dis. 2008;197:1000-1005 (Pubitemid 351590028)
21. Kaplan JE, Masur H, Holmes KK. Guidelines for the prevention of opportunistic infections among HIV-infected persons - 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51(RR-8):1-55.
22. French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K, et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet. 2000;355:2106-2111 (Pubitemid 30364659)
23. Foy HM, Wentworth B, Kenny GE, Kloeck JM, Grayston JT. Pneumococcal isolations from patients with pneumonia and control subjects in a prepaid medical care group. Am Rev Respir Dis. 1975;111:595-603.
24. Watt JP, O'Brien KL, Katz S, Bronsdon MA, Elliott J, Dallas J, et al. Nasopharyngeal versus oropharyngeal sampling for detection of pneumococcal carriage in adults. J Clin Microbiol. 2004;42:4974-4976 (Pubitemid 39506197)
25. Lieberman D, Shleyfer E, Castel H, Terry A, Harman-Boehm I, Delgado J, et al. Nasopharyngeal versus oropharyngeal sampling for isolation of potential respiratory pathogens in adults. J Clin Microbiol. 2006;44:525-528 (Pubitemid 43222247)
26. Greenberg D, Broides A, Blancovich I, Peled N, Givon-Lavi N, Dagan R. Relative importance of nasopharyngeal versus oropharyngeal sampling for isolation of Streptococcus pneumoniae and Haemophilus influenzae from healthy and sick individuals varies with age. J Clin Microbiol. 2004;42:4604-4609 (Pubitemid 39362378)
27. Hendley JO, Sande MA, Stewart PM, Gwaltney JM Jr. Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis. 1975;132:55-61.
28. Boersma WG, Lowenberg A, Holloway Y, Kuttschrutter H, Snijder JA, Koeter H. The role of antigen detection in pneumococcal carriers: a comparison between cultures and capsular antigen detection in upper respiratory secretions. Scand J Infect Dis. 1993;25:51-56
29. Klugman KP. Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infect Dis. 2001;1:85-91.
30. Lesprit P, Pédrono G, Molina JM, Goujard C, Girard PM, Sarrazin N, et al. Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults. AIDS. 2007;21:2425-2434 (Pubitemid 350145174)